Apigenin inhibits infectious bronchitis virus replication in ovo

11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

– OBJECTIVE: Infectious bronchitis virus (IBV), for which no effective drugs are available, is among the most important causes of economic loss within the poultry industry. Apigenin is a flavonoid that can be isolated from plants. Apigenin has low toxicity with anti-viral activity. However, the effects of apigenin against IBV remain unclear. MATERIALS AND METHODS: Thus, here we investigate the anti-viral effect of apigenin on IBV using 10 day-old embryonated eggs by determining the virus titer by embryo infective doses50 (EID50/mL) and determining IBV genomes copy number (per µL) of allantoic fluid. RESULTS: We found that apigenin protected embryonated eggs from IBV. Additionally, apigenin reduced the log titer of the IBV with a significant correlation of up to 9.4 times at 2 µg/ egg. Also, apigenin appears to significantly reduce IBV genomes copy number (per µL) in the allantoic fluid. CONCLUSIONS: Apigenin may be a promising approach for the treatment of IBV, since it protects embryonated eggs from IBV in ovo and suppresses viral replication.

Cite

CITATION STYLE

APA

Saadh, M. J., Jaber, S. A., Alaraj, M., & Alafnan, A. (2022). Apigenin inhibits infectious bronchitis virus replication in ovo. European Review for Medical and Pharmacological Sciences, 26(15), 5367–5371. https://doi.org/10.26355/eurrev_202208_29403

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free